Allergy Asthma Respir Dis.  2014 Sep;2(4):314-314. 10.4168/aard.2014.2.4.314.

ERRATUM: Author's Name Correction. The safety and efficacy of recombinant fibroblast growth factor 2 in human asthmatics: A pilot study

Affiliations
  • 1Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
  • 2Dong-A Pharm. Co. Ltd., Seoul, Korea.

Abstract

The fourth author's name was misprinted.


MeSH Terms

Fibroblast Growth Factor 2*
Humans
Pilot Projects*
Fibroblast Growth Factor 2
Full Text Links
  • AARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr